Tempus AI, Inc.
TEM
Jodie situation report
Tempus AI, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 28 directly disclosed connections are confirming.
- TEM's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if TEM's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind TEM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AZNAstraZeneca PLCcustomerFeb 24, 2026 ▾
“We issued a warrant to our customer AstraZeneca in conjunction with the signing of the MSA in November 2021.”
AZNAstraZeneca PLCpartnerMay 5, 2026 ▾
“For a reconciliation of adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with generally accepted accounting principles in the United States of America, or GAAP, and for additional information about adjusted EBIT…”
Depended on by
PSNLPersonalis, Inc.partnerMay 7, 2026 ▾
“We also have a collaboration with Tempus that enables Tempus to market our NeXT Personal ® Dx test to physicians for breast cancer, lung cancer, colorectal cancer and immuno-oncology monitoring, and to market and sell NeXT Personal to Tempus' pharmaceutical a…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 25 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TEM is currently a Follower in the organic co-movement group Speculative Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.